Actively Recruiting
Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC)
Led by Centre Paul Strauss · Updated on 2026-02-02
50
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
\[18 F\]fluorodeoxyglucose (18F-FDG) positron emission tomography-magnetic resonance imaging (PET/MRI) is a new hybrid imaging tool that has recently arrived in oncology, and is particularly promising. Its usefulness seems obvious in certain tumor types, but its place in the staging of cervical cancers has never been explored in a prospective trial to our knowledge. Previously, a comparative retrospective study from 2009 found a better sensitivity of PET fused to diagnostic MRI images compared to PET/CT (positron emission tomography/computed tomography) in the detection of metastatic lymph nodes (54 and 44% respectively). It was an a posteriori fusion of images, from images acquired by PET-CT.
CONDITIONS
Official Title
Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged from 18 years old and over
- Patients with presumed cervical cancer of stages IB2 to IVA based on clinical data and pelvic MRI, undergoing pre-treatment assessment
- For women of childbearing potential: adequate contraception throughout study participation
- Enrollment in a concomitant clinical trial is authorized
You will not qualify if you...
- Oncological history that could interfere with imaging interpretation, except cervical cancer
- Proven extra-nodal metastasis before study participation
- Contraindication to MRI or to injection of gadolinium-based contrast agents
- Contraindication to lumbo-aortic lymphadenectomy
- Persons deprived of liberty
- Minors or patients under guardianship or supervision
- Patients under judicial protection
- Patients unable to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut de cancérologie Strasbourg Europe
Strasbourg, France, 67033
Actively Recruiting
Research Team
C
Claire VIT
CONTACT
M
Manon VOEGELIN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here